Less than two months since the coronavirus vaccine arrived in Wyoming, around 10% of the state’s residents have received at least the first dose.
According to the Wyoming Department of Health, 57,063 first vaccine doses had been administered across the state as of Monday.
Wyoming has received 65,850 first doses of the two vaccines, split almost evenly between the Pfizer and Moderna medicines, meaning that 87% of the first doses have been administered.
The state has received 36,100 of the second doses for both vaccines and has administered 16,192 of them, a little less than half (45%).
There is about a three-week span between a patient receiving the first and second doses. Many counties have received second doses but haven’t yet administered all of them.
As of Sunday, Weston County was the only county in the state that hadn’t administered any second doses of the vaccine.
Counts provided by the WDH don’t include federal doses provided separately and directly for tribal, VA and military facilities.
All but one of the state’s 23 counties were administering vaccines to the phase 1B group, which includes people 65 and older. This phase was expanded earlier in the month to allow for people between the ages of 65 and 70 to be eligible for the the vaccine.
Campbell County was the only one still administering vaccines only to the phase 1A group.
The overall phase 1 plan describes three general groupings for early vaccine eligibility:
- Phase 1A includes healthcare providers, first responders, long-term care facility staff and others at high risk for exposure to COVID-19.
- Phase 1B now focuses on some frontline essential workers, individuals 65 and over and individuals with certain medical conditions.
- Phase 1C includes homeless individuals, people living in congregate settings and other essential workers as defined by the federal Cybersecurity and Infrastructure Security Agency.
While the phase 1C priority group descriptions are now available, counties will likely not be vaccinating phase 1C groups until later in the year due to limited vaccine supply.
The vaccine is being administered at no cost to patients.
